Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma

dc.contributor.author	Bulut, Tangul
dc.contributor.author	Yalcin, Arzu Didem
dc.contributor.author	Betul, Celik
dc.contributor.author	Genc, Gizem Esra
dc.contributor.author	Kose, Samet
dc.contributor.author	Gocmen, Ayse Yesim
dc.contributor.author	Kiraz, Kamil
dc.contributor.author	Harman, Rezzan
dc.contributor.author	Bulut, Irem
dc.contributor.author	Gumuslu, Saadet
dc.date.accessioned	2021-06-29T10:32:40Z
dc.date.available	2021-06-29T10:32:40Z
dc.date.issued	2016
dc.identifier.issn	0105-4538
dc.identifier.uri	http://openaccess.sanko.edu.tr/xmlui/handle/20.500.12527/287
dc.language.iso	English	en_US
dc.publisher	WILEY-BLACKWELL, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA	en_US
dc.rights	info:eu-repo/semantics/closedAccess	en_US
dc.title	Omalizumab treatment decreased IL-1 beta and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma	en_US
dc.type	Other	en_US
dc.relation.journal	ALLERGY	en_US
dc.identifier.issue	Special Issue	en_US
dc.identifier.startpage	257	en_US
dc.identifier.endpage	257	en_US
dc.identifier.volume	71	en_US
dc.contributor.authorID	0000-0003-3113-985X : Gizem Esra Genç	en_US
dc.contributor.authorID	0000-0002-1021-3662 : Saadet Gumuslu	en_US
dc.identifier.wos	000383679801359	en_US
dc.contributor.sankoauthor	Rezzan Harman	en_US